By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capricor Announces Upcoming Events In Duchenne Muscular Dystrophy Program 5/31/2017 8:53:42 AM
Capricor Announces Formation Of Duchenne Muscular Dystrophy Advisory Board 5/25/2017 9:31:07 AM
Capricor Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/16/2017 10:57:25 AM
SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results 5/12/2017 6:09:04 AM
Capricor Therapeutics, Inc. Announces Private Placement Of Common Stock 5/8/2017 8:21:15 AM
Capricor Therapeutics, Inc. To Hold First Quarter 2017 Financial Results And Corporate Update Conference Call On Monday, May 15 5/5/2017 8:39:09 AM
Capricor Therapeutics, Inc. Announces Positive Six-Month Results From The Randomized Phase I/II HOPE Clinical Trial In Duchenne Muscular Dystrophy 4/25/2017 6:28:03 AM
Capricor Therapeutics, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/16/2017 11:23:42 AM
Capricor Therapeutics, Inc. To Hold Fourth Quarter And Full Year 2016 Financial Results And Corporate Update Conference Call On Wednesday, March 15 3/7/2017 11:13:20 AM
Capricor Therapeutics, Inc. Terminates Natriuretic Peptide Program Deal With The Mayo Clinic 2/17/2017 9:44:56 AM
12345678910
//-->